Publicaciones en colaboración con investigadores/as de VU University Medical Center (14)

2023

  1. Cohort profile: the ESC EURObservational Research Programme Non-ST-segment elevation myocardial infraction (NSTEMI) Registry

    European Heart Journal - Quality of Care and Clinical Outcomes, Vol. 9, Núm. 1, pp. 8-15

  2. Erratum: Author Correction: Common variants in Alzheimer's disease and risk stratification by polygenic risk scores (Nature communications (2021) 12 1 (3417))

    Nature communications

2022

  1. Mapping genomic loci implicates genes and synaptic biology in schizophrenia

    Nature, Vol. 604, Núm. 7906, pp. 502-508

2021

  1. Common variants in Alzheimer's disease and risk stratification by polygenic risk scores

    Nature communications, Vol. 12, Núm. 1, pp. 3417

  2. Comparison of the PU.1 transcriptional regulome and interactome in human and mouse inflammatory dendritic cells

    Journal of Leukocyte Biology, Vol. 110, Núm. 4, pp. 735-751

  3. Toxic iron species in lower-risk myelodysplastic syndrome patients: course of disease and effects on outcome

    Leukemia, Vol. 35, Núm. 6, pp. 1745-1750

2020

  1. C9orf72, age at onset, and ancestry help discriminate behavioral from language variants in FTLD cohorts

    Neurology, Vol. 95, Núm. 24, pp. E3288-E3302

2019

  1. Phenotypic factors associated with amisulpride-induced weight gain in first-episode psychosis patients (from the OPTiMiSE cohort)

    Acta Psychiatrica Scandinavica, Vol. 140, Núm. 3, pp. 283-290

  2. Updated European Consensus Statement on diagnosis and treatment of adult ADHD

    European Psychiatry, Vol. 56, pp. 14-34

2015

  1. Aberrant Epstein-Barr virus antibody patterns and chronic lymphocytic leukemia in a Spanish multicentric case-control study -No section-

    Infectious Agents and Cancer, Vol. 10, Núm. 1

2014

  1. Qualifying unmet needs and improving standards of care in psoriatic arthritis

    Arthritis Care and Research, Vol. 66, Núm. 12, pp. 1759-1766

2006

  1. The potential of the European network of congenital anomaly registers (EUROCAT) for drug safety surveillance: A descriptive study

    Pharmacoepidemiology and Drug Safety, Vol. 15, Núm. 9, pp. 675-682

2004

  1. Continuing outcomes relevant to Evista: Breast cancer incidence in postmenopausal osteoporotic women in a randomized trial of raloxifene

    Journal of the National Cancer Institute, Vol. 96, Núm. 23, pp. 1751-1761

  2. Health-related quality of life and radiographic vertebral fracture

    Osteoporosis International, Vol. 15, Núm. 2, pp. 113-119